Jan Halbritter
Overview
Explore the profile of Jan Halbritter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
2458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Degenhardt J, Tolkach Y, Amin M, Mosiello G, Baydar D, Cornec-Le Gall E, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39979023
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is caused by heterozygous germline variants in the fumarate hydratase (FH) gene [1,2]. Inheritance follows an autosomal dominant pattern. Loss of FH...
2.
Ibel A, Bhardwaj R, Yilmaz D, Kong S, Wendlinger S, Papaioannou D, et al.
bioRxiv
. 2025 Feb;
PMID: 39975003
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent genetic kidney disorder, affecting over 10 million individuals worldwide. Cystic expansion typically progresses to kidney failure and also involves the...
3.
Jawaid T, Elbarougy D, Lavu S, Buia G, Senum S, Olinger E, et al.
J Am Soc Nephrol
. 2025 Feb;
PMID: 39899384
Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common, inherited nephropathy often resulting in kidney failure. It is genetically heterogeneous; along with the major genes, PKD1 and PKD2, at...
4.
Elhassan E, Collins K, Heneghan S, Gilbert E, Yang H, Senum S, et al.
J Nephrol
. 2025 Jan;
PMID: 39883360
Background: Autosomal dominant polycystic kidney disease (ADPKD) is caused primarily by pathogenic variants in the PKD1 and PKD2 genes. Although the type of ADPKD variant can influence disease severity, rare,...
5.
Geertsema P, Gansevoort R, Arici M, Capasso G, Cornec-Le-Gall E, Furlano M, et al.
Nephrol Dial Transplant
. 2025 Jan;
PMID: 39848914
A substantial number of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) undergo a nephrectomy, especially in work-up for a kidney transplantation. Currently, there is no evidence-based algorithm to guide...
6.
Zagorec N, Calamel A, Delaporte M, Olinger E, Orr S, Sayer J, et al.
Am J Kidney Dis
. 2024 Dec;
PMID: 39732359
Rationale & Objective: Monoallelic predicted loss-of-function (pLoF) variants in IFT140 have recently been associated with an autosomal dominant polycystic kidney disease (ADPKD)-like phenotype. This study enhanced the characterization of this...
7.
Wolff C, Aiello V, Elhassan E, Cristalli C, Lerario S, Paccapelo A, et al.
Clin J Am Soc Nephrol
. 2024 Dec;
20(3):397-409.
PMID: 39705090
No abstract available.
8.
Boeckhaus J, Gale D, Simon J, Ding J, Zhang Y, Bergmann C, et al.
Kidney Int Rep
. 2024 Dec;
9(12):3490-3500.
PMID: 39698346
Introduction: Large-scale trials showed positive outcomes of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in adults with chronic kidney disease (CKD). Whether the use of SGLT2i is safe and effective in patients with...
9.
Bazua-Valenti S, Brown M, Zavras J, Riedl Khursigara M, Grinkevich E, Sidhom E, et al.
J Clin Invest
. 2024 Dec;
134(24).
PMID: 39680459
The trafficking dynamics of uromodulin (UMOD), the most abundant protein in human urine, play a critical role in the pathogenesis of kidney disease. Monoallelic mutations in the UMOD gene cause...
10.
Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, et al.
Nephrol Dial Transplant
. 2024 Dec;
PMID: 39673311
Background And Hypothesis: Donor-derived cell-free DNA (dd-cfDNA) shows good diagnostic performance for the detection of antibody-mediated rejection (AMR) in kidney transplant recipients (KTR). However, the clinical benefits of dd-cfDNA monitoring...